* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : therapeutics;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/aciclovir
2024
false
false
false
France
French
guideline
patients guideline
drug information
risk management
acyclovir
Accidental Drug Ingestion
Muco-adhesive Buccal Tablet Dosage Form

---
https://ansm.sante.fr/tableau-marr/methotrexate-per-os
2024
false
false
false
France
French
guidelines for drug use
risk management
methotrexate
administration, oral
patient education handout
medication errors

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2024-5-8-fevrier
2024
false
false
false
France
French
pharmacovigilance note
nirmatrelvir and ritonavir drug combination
nirmatrelvir and ritonavir drug combination
immunosuppressive agents
drug therapy, combination
drug interactions

---
https://ansm.sante.fr/tableau-marr/adalimumab
2024
false
false
false
France
French
Adalimumab
risk management
continuity of patient care
drug information
adult
child
patient education handout

---
https://medqual.fr/images/2024-COTRIMOXAZOLE.pdf
2024
France
patient education handout
drug information
trimethoprim
sulfamethoxazole
Trimethoprim
co-trimazole
Sulfamethoxazole

---
https://www.irsst.qc.ca/publications-et-outils/publication-irsst/i/101203/n/fusion-modelesmusculosquelettiques-colonne-lombaire-prevention-readaptation-travailleurs
2024
Canada
technical report
colon
Lumbar Spine
lumbar spinal fusion
Preventive Intervention
rehabilitation therapy, nos
Gene Fusion
lumbar vertebrae
rehabilitation
Merge
Rehabilitation
Validation
Model
Prevention
Prevention Study
Validation Batch

---
https://ansm.sante.fr/tableau-marr/fentanyl-6
2024
false
false
false
France
French
fentanyl
Fentanyl Citrate
risk management
administration, sublingual
guidelines for drug use
fentanyl
patients guideline
adult
breakthrough pain
drug prescriptions
narcotics
Cancer Pain

---
https://www.has-sante.fr/jcms/p_3449778/fr/crysvita-burosumab-hypophosphatemie-liee-au-fgf23
2024
false
false
false
France
French
evaluation of the transparency committee
burosumab

---
https://drogues-sante-societe.ca/les-mecaniques-de-jeux-de-hasard-et-dargent-dans-les-jeux-mobiles-gratuits-pour-les-enfants-dun-modele-economique-au-conditionnement-a-laddiction/
2024
Canada
journal article
Offspring
Mechanism
Child
Biological Model
dependent drug abuse
Package Dosing Unit
mechanics
child, nos
Economics
product packaging
silver
Addiction
Model Number
Mobile
Conditioning Clinical Trial Setting
child
Money
Drug Package
models, economic
Lipid R1 MRI
gambling
Silver
gambling
mobility, nos
Mobilization Clinical Trial Setting
behavior, addictive

---
https://www.cfp.ca/content/70/2/e31
2024
Canada
journal article
burns
Rural Area
Departure
On Treatment
Biomaterial Treatment
Burn, CTCAE
Emergency
During Treatment
Smoking Method of Administration
Emergency Room
Therapy Object
Urgency
Approach
Burn
Treatment
No Treatment for Diabetes
Treatment Study
Treat
Treatment Epoch
burn injury, nos
emergency treatment
GDC Treatment Frequency Terminology

---
https://www.cochrane.org/fr/CD013474/HAEMATOL_le-traitement-dentretien-apres-un-traitement-anterieur-est-il-plus-efficace-que-lobservation-ou-le
2024
United Kingdom
review of literature
french abstract
adulthood
Legal Adult
NCI CTEP SDC Chronic Lymphoid Leukemia Sub-Category Terminology
What Month is it
Observation
Illinois
Treatment Compliance
leukemia, lymphoid
Interleukin
leukaemia
Observation Study Epoch
adult
interviews as topic
Until Effective
chronic lymphocytic leukemia
leukemia, lymphocytic, chronic, B-Cell
Chronic Lymphocytic Leukemia
placebos
Prior Therapy
Maintenance Therapy
patient compliance
interview
Israel
Post-Therapy

---
https://ansm.sante.fr/tableau-acces-derogatoire/inspra-25-mg-comprime-pellicule
2024
false
false
false
France
French
Eplerenone
continuity of patient care
guidelines for drug use
adult
hyperaldosteronism
technical report

---
https://ansm.sante.fr/actualites/abrogation-de-certaines-autorisations-de-mise-sur-le-marche-de-generiques-de-tecfidera
2024
false
false
false
France
French
drug information
drugs, generic
Dimethyl Fumarate
legislation, pharmacy
europe
drug approval
dimethyl fumarate
legislation, drug

---
https://www.has-sante.fr/jcms/p_3482873/fr/cibinqo-abrocitinib-dermatite-atopique-da
2024
false
false
false
France
abrocitinib
treatment outcome
insurance, health, reimbursement
Janus Kinase Inhibitors
administration, oral
adult
evaluation of the transparency committee
dermatitis, atopic
abrocitinib

---
https://www.has-sante.fr/jcms/p_3486160/fr/jyseleca-filgotinib-rectocolite-hemorragique-rch
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Janus Kinase Inhibitors
filgotinib
adult
evaluation of the transparency committee
colitis, ulcerative
filgotinib

---
https://www.has-sante.fr/jcms/p_3483264/fr/fluenz-tetra-vaccin-grippal-quadrivalent-vivant-attenue-nasal-vaccin-antigrippal
2024
false
false
false
France
evaluation of the transparency committee
Trivalent Live-Attenuated Influenza Vaccine
preventive immunization/medication
Nasal Route of Administration
Trial Element Duration
Influenza Vaccine
influenza virus vaccine
vaccines, attenuated
Quadrivalent Influenza Vaccine
Nasal Dosage Form
vaccination
nose, nos
influenza vaccines
Tea Leaf
Ezatiostat Hydrochloride
attenuated by

---
https://www.has-sante.fr/jcms/p_3486233/fr/xeljanz-tofacitinib-arthrite-juvenile-idiopathique-aji
2024
false
false
false
France
Product containing only tofacitinib in oral dose form (medicinal product form)
tablets
pharmaceutical solutions
administration, oral
treatment outcome
insurance, health, reimbursement
child
adolescent
Polyarticular juvenile idiopathic arthritis
tofacitinib
evaluation of the transparency committee
arthritis, juvenile
Polyarticular Juvenile Idiopathic Arthritis
tofacitinib

---
https://www.has-sante.fr/jcms/p_3487097/fr/columvi-glofitamab-lymphome-diffus-a-grande-cellule-b-ldgcb
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
infusions, intravenous
Antineoplastic Agents, Immunological
lymphoma, large B-Cell, diffuse
Recurrent Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
glofitamab
evaluation of the transparency committee
glofitamab

---
https://ansm.sante.fr/actualites/en-cas-de-rhume-evitez-les-medicaments-vasoconstricteurs-par-voie-orale
2024
false
false
false
France
French
common cold
administration, oral
nasal decongestants
pseudoephedrine
pharmacovigilance note
patients guideline
nasopharyngitis
pseudoephedrine, combinations
myocardial infarction
stroke
Posterior reversible encephalopathy syndrome (disorder)
Reversible cerebral vasoconstriction syndrome (disorder)

---
https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/actualites/tensions-dapprovisionnement-en-corgard-80-mg-nadolol-ce-medicament-doit-etre-reserve-a-certains-patients-atteints-de-troubles-du-rythme-dorigine-genetique
2024
false
false
false
France
French
nadolol
nadolol
drug information
drug information
guideline
guideline
patient education handout
patient education handout
Genetic cardiac rhythm disease
Genetic cardiac rhythm disease
arrhythmias, cardiac
arrhythmias, cardiac
nadolol
nadolol
arrhythmias, cardiac
arrhythmias, cardiac

---
https://ansm.sante.fr/tableau-marr/eculizumab-2
2024
false
false
false
France
French
risk management
eculizumab
eculizumab
eculizumab
guidelines for drug use
patient education handout
patients guideline
antibiotic prophylaxis
infusions, intravenous
Infections
sepsis
Drug-Related side effects and adverse reactions
meningococcal infections
vaccination
meningococcal vaccines

---
https://ansm.sante.fr/actualites/point-de-situation-des-approvisionnements-en-auto-injecteurs-dadrenaline
2024
false
false
false
France
French
drug information
epinephrine
france
Epinephrine autoinjector (physical object)

---
https://ansm.sante.fr/tableau-acces-derogatoire/bylvay
2024
false
false
false
France
French
insurance, health, reimbursement
odevixibat
odevixibat
summary of product characteristics
package leaflet
guidelines for drug use
infant
child
pruritus
cholestatic pruritus in Alagille syndrome
alagille syndrome

---
https://ansm.sante.fr/tableau-marr/etanercept-1
2024
false
false
false
France
French
risk management
Etanercept
patients guideline
drug information
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense

---
https://www.has-sante.fr/jcms/p_3443053/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2
2024
false
false
false
France
adult
treatment outcome
insurance, health, reimbursement
Unresectable HER2-Positive Breast Carcinoma
Metastatic HER2-Positive Breast Carcinoma
neoplasm metastasis
trastuzumab deruxtecan
guidelines for drug use
Antineoplastic Agents, Immunological
infusions, intravenous
evaluation of the transparency committee
breast neoplasms
trastuzumab deruxtecan
Trastuzumab

---
https://www.has-sante.fr/jcms/p_3423139/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2024
false
false
false
France
Generalized pustular psoriasis
spesolimab
adult
treatment outcome
insurance, health, reimbursement
infusions, intravenous
evaluation of the transparency committee
psoriasis
spesolimab

---
https://www.has-sante.fr/jcms/p_3412521/fr/abecma-idecabtagene-vicleucel-myelome-multiple
https://www.has-sante.fr/jcms/p_3412521/en/abecma-idecabtagene-vicleucel-myelome-multiple
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
Recurrent Multiple Myeloma
Refractory Multiple Myeloma
idecabtagene vicleucel
infusions, intravenous
Antineoplastic Agents, Immunological
evaluation of the transparency committee
idecabtagene vicleucel
multiple myeloma

---
https://ansm.sante.fr/tableau-acces-derogatoire/upstaza
2024
false
false
false
France
French
Eladocagene Exuparvovec
drug information
infant
Aromatic-L-Amino-Acid decarboxylases
Aromatic-L-Amino-Acid Decarboxylase
aromatic amino acid decarboxylase deficiency

---
https://ansm.sante.fr/tableau-acces-derogatoire/tecartus-0-4-2-x-108-cellules-dispersion-pour-perfusion
2024
false
false
false
France
French
brexucabtagene autoleucel
drug information
Refractory B Acute Lymphoblastic Leukemia
precursor cell lymphoblastic Leukemia-Lymphoma
brexucabtagene autoleucel
gene therapy

---
https://ansm.sante.fr/tableau-acces-derogatoire/ivosidenib
2024
false
false
false
France
French
administration, oral
summary of product characteristics
cholangiocarcinoma
guidelines for drug use
leukemia, myeloid, acute
glioma
myelodysplastic syndromes
antineoplastic agents
ivosidenib
ivosidenib
neoplasm metastasis
package leaflet

---
https://ansm.sante.fr/tableau-acces-derogatoire/sotrovimab-500-mg-solution-a-diluer-pour-perfusion-intraveineuse-xevudy
2024
false
false
false
France
French
infusions, intravenous
drug information
adult
adolescent
COVID-19
sotrovimab
sotrovimab

---
https://ansm.sante.fr/tableau-marr/dabigatran
2024
false
false
false
France
French
guidelines for drug use
guidelines for drug use
risk management
risk management
Dabigatran
Dabigatran
Dabigatran
Dabigatran
dabigatran etexilate
dabigatran etexilate
administration, oral
administration, oral
antithrombins
antithrombins
antithrombins
antithrombins
continuity of patient care
continuity of patient care
hemorrhage
hemorrhage
risk
risk
adult
adult
child
child

---
https://ansm.sante.fr/tableau-acces-derogatoire/keytruda-25-mg-ml-solution-a-diluer-pour-perfusion#
2024
false
false
false
France
French
drug information
triple negative breast neoplasms
pembrolizumab
pembrolizumab
summary of product characteristics
package leaflet
guidelines for drug use
adult
Early Stage Triple-Negative Breast Carcinoma
Locally Advanced Triple-Negative Breast Carcinoma
inflammatory breast neoplasms
Antineoplastic Agents, Immunological
endometrial neoplasms
clear cell renal cell carcinoma
renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions

---
https://www.has-sante.fr/jcms/p_3299900/fr/resultats-des-iqss-mesure-de-la-satisfaction-et-de-l-experience-des-patients-hospitalises-en-soins-de-suite-et-de-readaptation-e-satis-ssr
2024
false
false
false
France
technical report
inpatients
patient satisfaction
measures
resulting in
weights and measures
subacute care
rehabilitation therapy, nos
patient care
hospital admission, nos
has patient
rehabilitation

---
https://ansm.sante.fr/actualites/nulojix-belatacept-pour-la-greffe-de-rein-recommandations-temporaires-pour-garantir-la-continuite-des-soins
2024
false
false
false
France
French
guidelines for drug use
guidelines for drug use
Abatacept
Abatacept

---
https://ansm.sante.fr/tableau-marr/selexipag
2024
false
false
false
France
French
risk management
Uptravi
medication errors
selexipag
patients guideline
guidelines for drug use
Wrong dose
selexipag

---
https://ansm.sante.fr/tableau-acces-derogatoire/adcetris-50-mg-poudre-pour-solution-a-diluer-pour-perfusion
2024
false
false
false
France
French
continuity of patient care
guideline
hodgkin disease
child
adolescent
adult
antineoplastic combined chemotherapy protocols
brentuximab vedotin
Brentuximab Vedotin
infusions, intravenous

---
https://ansm.sante.fr/tableau-acces-derogatoire/berinert-500-ui-mg-poudre-et-solvant-pour-solution-injectable-perfusion
2024
false
false
false
France
French
complement C1 inhibitor protein
complement C1 inhibitor protein
guidelines for drug use
guidelines for drug use
continuity of patient care
continuity of patient care
salvage therapy
salvage therapy
graft rejection
graft rejection
Humoral rejection
Humoral rejection
heart transplantation
heart transplantation
kidney transplantation
kidney transplantation
lung transplantation
lung transplantation
infusions, intravenous
infusions, intravenous
complement C1 inhibitor protein
complement C1 inhibitor protein
technical report
technical report

---
https://ansm.sante.fr/tableau-marr/tetradecyl-sulfate-de-sodium
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
sodium tetradecyl sulfate
sclerosing solutions
sodium tetradecyl sulfate
sodium tetradecyl sulfate
injections, intravenous
sclerotherapy

---
https://ansm.sante.fr/tableau-marr/teclistamab
2024
false
false
false
France
French
popular works
drug information
Teclistamab
risk management
teclistamab

---
https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/venetoclax
2024
false
false
false
France
French
risk management
venetoclax
venetoclax
patient education handout
tumor lysis syndrome
administration, oral
antineoplastic agents

---
https://ansm.sante.fr/tableau-marr/tacrolimus
2024
false
false
false
France
French
risk management
tacrolimus
tacrolimus
administration, oral
guidelines for drug use
patient education handout
continuity of patient care
immunosuppressive agents

---
https://ansm.sante.fr/tableau-marr/cladribine
2024
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests

---
https://ansm.sante.fr/tableau-marr/inebilizumab
2024
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection

---
https://ansm.sante.fr/tableau-acces-derogatoire/kaftrio-75-mg-50-mg-100-mg-comprime-pellicule-kalydeco-150-mg-comprime-pellicule
2024
false
false
false
France
French
cystic fibrosis
guidelines for drug use
continuity of patient care
drug therapy, combination
administration, oral
ivacaftor, tezacaftor and elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
tezacaftor
elexacaftor
adult
adolescent
ivacaftor
trikafta
drug combinations
drug information

---
https://ansm.sante.fr/tableau-marr/ponesimod
2024
false
false
false
France
French
risk management
ponesimod
ponesimod
administration, oral
ponesimod
ponvory
guidelines for drug use
patients guideline
pregnancy
continuity of patient care
ponesimod
adult
multiple sclerosis, relapsing-remitting
drug monitoring
immunosuppressive agents
immunosuppressive agents
immunosuppressive agents

---
https://ansm.sante.fr/tableau-marr/nalmefene
2024
false
false
false
France
French
risk management
nalmefene
nalmefene
guidelines for drug use
patient education handout
administration, oral
patient compliance
patients guideline
alcohol drinking
continuity of patient care
nalmefene
alcoholism
adult
algorithms
Psychosocial Intervention

---
https://ansm.sante.fr/tableau-marr/capsaicine
2024
false
false
false
France
French
risk management
guidelines for drug use
capsaicin
administration, cutaneous
continuity of patient care
capsaicin

---
https://ansm.sante.fr/tableau-marr/olanzapine
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Olanzapine
risk management
olanzapine
injections, intramuscular
Delayed-Action preparations
Olanzapine
metabolic diseases
continuity of patient care
drug compounding
injections, intramuscular
olanzapine pamoate
olanzapine pamoate
schizophrenia
antipsychotic agents
antipsychotic agents
medication errors
Post-injection delirium sedation syndrome (finding)

---
https://ansm.sante.fr/tableau-acces-derogatoire/selpercatinib-20-40-et-80mg-gelule
2024
false
false
false
France
French
selpercatinib
administration, oral
carcinoma, non-small-cell lung
advanced RET fusion-positive non-small cell lung cancer
Product containing only selpercatinib in oral dose form (medicinal product form)
drug information
selpercatinib
pyrazoles
pyridines

---
https://ansm.sante.fr/tableau-marr/tolvaptan
2024
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout

---
https://ansm.sante.fr/tableau-atu-rtu/abecma-260-500-x-106-cellules-dispersion-pour-perfusion
2024
false
false
false
France
French
guidelines for drug use
Idecabtagene Vicleucel
Idecabtagene Vicleucel
gene therapy
immunotherapy, adoptive
adult
multiple myeloma
recurrence
Refractory Multiple Myeloma
idecabtagene vicleucel
idecabtagene vicleucel
Recurrent Multiple Myeloma
genetic therapy

---
https://ansm.sante.fr/tableau-marr/ranibizumab
2024
false
false
false
France
French
risk management
Ranibizumab
Ranibizumab
patients guideline
intravitreal injections
patient education handout
package leaflet
ranibizumab

---
https://www.has-sante.fr/jcms/p_3269932/fr/reeducation-de-l-appareil-locomoteur-dans-les-pathologies-neuro-musculaires-suite-a-l-introduction-de-nouvelles-technologies-biotherapie-instrumentation-rachidienne-reentrainement-a-l-effort-note-de-cadrage
2024
false
false
false
France
practice guideline
news
Pathology
Technology
instrumentalist
neurology
Disorders
technology
Pathology
Pathology
rehabilitation therapy, nos
biological therapy
musculoskeletal system
muscle, nos
physical exertion
device, nos
Pathology
vertebral column, nos
instrument, nos
Pathology
exertion, nos
muscular diseases
Pathology
myofunctional therapy
Pathology

---
https://ansm.sante.fr/tableau-acces-derogatoire/yescarta-0-4-2-x-108-cellules-dispersion-pour-perfusion#
2024
false
false
false
France
French
axicabtagene ciloleucel
axicabtagene ciloleucel
biological products
Antineoplastic Agents, Immunological
Recurrent High Grade B-Cell Lymphoma
lymphoma, large B-Cell, diffuse
adult
Refractory High Grade B-Cell Lymphoma
drug information
immunotherapy, adoptive
antigens, CD19

---
https://ansm.sante.fr/tableau-marr/insuline-glargine
2024
false
false
false
France
French
Insulin Glargine
medication errors
risk management
insulin glargine
guidelines for drug use
patients guideline

---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide

---
https://ansm.sante.fr/tableau-marr/pomalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide

---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet

---
https://medqual.fr/images/GP/ATB/2024-AMOXICILLINE-ACIDE-CLAVULANIQUE.pdf
2024
false
false
false
France
patient education handout
amoxicillin-potassium clavulanate combination
amoxycillin with clavulanate potassium
amoxicillin
clavulanic acid
due to
Practice
amoxicillin
clavulanic acid

---
https://medqual.fr/images/2024-C3G.pdf
2024
false
false
false
France
patient education handout
third generation cephalosporin, nos
due to
generations
Practice
cephalosporins
family characteristics

---
https://www.has-sante.fr/jcms/p_3500210/fr/bylvay-odevixibat-prurit-cholestatique-associe-au-syndrome-d-alagille
2024
false
false
false
France
cholestatic pruritus in Alagille syndrome
Cholestatic pruritus (disorder)
treatment outcome
insurance, health, reimbursement
child
infant
administration, oral
odevixibat
evaluation of the transparency committee
odevixibat
alagille syndrome

---
https://www.has-sante.fr/jcms/p_3500381/fr/merci
2024
France
health technology assessment
Guide Device
Bronchoalveolar Biopsy Specimen
guiding catheter
catheterization
TNFSF13B wt Allele
Handbook
Catheter Device
Thank You
Catheter
Balloon Device

---
https://www.has-sante.fr/jcms/p_3500384/fr/flowgate2
2024
France
health technology assessment
Catheter Device
Bronchoalveolar Biopsy Specimen
guiding catheter
Balloon Device
Handbook
Guide Device
catheterization
Catheter

---
https://www.has-sante.fr/jcms/p_3500387/fr/dupixent-dupilumab-dermatite-atopique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
dupilumab
injections, subcutaneous
adult
Adult atopic dermatitis (disorder)
evaluation of the transparency committee
dermatitis, atopic
dupilumab

---
https://www.has-sante.fr/jcms/p_3500390/fr/lepticur-chlorhydrate-de-tropatepine-syndrome-parkinsonien-induit-par-les-neuroleptiques
2024
false
false
false
France
Tropatepine hydrochloride (substance)
Parkinsonism caused by neuroleptic drug (disorder)
treatment outcome
insurance, health, reimbursement
tropatepine
administration, oral
tablets
-
evaluation of the transparency committee
parkinson disease, secondary
tropatepine
antipsychotic agents

---
https://www.inspq.qc.ca/publications/3446
2024
Canada
technical report
conception
Evaluation
Conception
Projected
Regional Disease
Vulnerability to COVID-19
conception
rehabilitation
Design
fertilization
climate
Assessment
public health
Delta
Projection
Implementation
adaptation, nos
Modification
CDISC SEND Study Design Terminology
Modified
Local-Regional
evaluation studies as topic
changing
Physical Examination
climate change
Public Health
habilitation
Acclimatization
Conception Age
Global Change/UV
Local
Assessment

---
https://drees.solidarites-sante.gouv.fr/publications-communique-de-presse/etudes-et-resultats/nombre-de-lits-en-reanimation-ladaptation-du
2024
France
journal article
hospital bed, nos
bed size
Drug Delivery System Category
Resuscitation
Reasoning
hospitals
habilitation
Number
hospital bed capacity
Human Activity Profile
crisis, nos
resuscitation
COVID-19 Infection
rehabilitation
Adaptation
Adjustment
Adaptive Study Design Indicator
Drug Delivery System
adaptation, nos
Device System
COVID-19
Fit

---
https://www.inrs.fr/publications/bdd/eficatt/fiche.html?refINRS=EFICATT_Infections%20%C3%A0%20bact%C3%A9ries%20multir%C3%A9sistantes%20(BMR)%20digestives
2024
France
scientific and technical information
bacterium, nos
digestive tract function, nos
bacteria
gastrointestinal agents
digestion
digestants
digestant, nos
Basal Metabolic Rate
Percent of Bacteria
infectious disease, nos
Bacteria
Bacterial Count
Bacteria Present
Digestion
Infections
Infection

---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related

---
https://www.has-sante.fr/jcms/p_3500011/fr/bimzelx-bimekizumab-psoriasis-en-plaques
2024
France
evaluation of the transparency committee
psoriasis
bimekizumab
bimekizumab
bone plates
psoriasis vulgaris
Bimekizumab
Psoriasis
Patch

---
https://www.has-sante.fr/jcms/p_3500927/fr/adempas-riociguat-hypertension-arterielle-pulmonaire-htap
2024
France
evaluation of the transparency committee
riociguat
riociguat
Pulmonary Arterial Hypertension
Adempas
Pulmonary Arterial Hypertension
pulmonary hypertension, nos
hypertensive disease, nos
riociguat
Riociguat

---
https://www.has-sante.fr/jcms/p_3423859/fr/reflux-gastro-oesophagien-chez-l-enfant-de-moins-d-un-an-definitions-prise-en-charge-et-pertinence-des-traitements-pharmacologiques
2024
France
guideline
Improved
patient care management
pharmacology
Scientific Equipment
child, nos
Child Individual
pharmacologist
Definitive
Tool
child
Child Relation
Enhance
tool, nos
gastroesophageal reflux
Perflutren Lipid Microspheres
Professional Practice
professional practice
Pharmacotherapy
Gastroesophageal Reflux
gastroesophageal reflux
Adverse Event Definitely Related to Intervention
Charge
drug therapy

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024003/article/00001-fra.htm
2024
Canada
technical report
CDISC SDTM Submission Domain Abbreviation Terminology
residence characteristics
Story
health
Submission Domain
Correlation
Rating Myself
Respect
Individual
community
Use
Self-Assessment
Person
appraiser
Self Assessment
Self-Report
Estimate
Statistical Estimation
SANT Domain

---
https://www.has-sante.fr/jcms/p_3501627/fr/skyrizi-risankizumab-maladie-de-crohn
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
infusions, intravenous
injections, subcutaneous
Interleukin Inhibitors
risankizumab
evaluation of the transparency committee
crohn disease
risankizumab

---
https://www.has-sante.fr/jcms/p_3501976/fr/cosentyx-secukinumab-rhumatisme-psoriasique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
secukinumab
injections, subcutaneous
Interleukin Inhibitors
adult
Interleukin-17
evaluation of the transparency committee
arthritis, psoriatic
secukinumab

---
https://ansm.sante.fr/informations-de-securite/paxlovid-nirmatrelvir-ritonavir-rappel-des-interactions-medicamenteuses-avec-certains-immunosuppresseurs-notamment-le-tacrolimus-pouvant-etre-fatales
2024
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
drug interactions
nirmatrelvir and ritonavir drug combination
nirmatrelvir
immunosuppressive agents
tacrolimus
COVID-19 Drug Treatment
adult
nirmatrelvir and ritonavir
tacrolimus

---
https://ansm.sante.fr/actualites/decision-du-21-03-2024-cadre-de-prescription-compassionnelle-de-tacrolimus-0-1-pommade
2024
false
false
false
France
French
drug information
tacrolimus
administration, cutaneous
ointments
legislation, pharmacy
adult
child
adolescent
vitiligo
tacrolimus

---
https://ansm.sante.fr/tableau-acces-derogatoire/tacrolimus#
2024
false
false
false
France
French
tacrolimus
drug information
administration, cutaneous
vitiligo

---
https://www.has-sante.fr/jcms/p_3502158/fr/brinzolamide/timolol-biogaran-brinzolamide/timolol-glaucome-a-angle-ouvert-et-hypertonie-intraoculaire
2024
France
evaluation of the transparency committee
glaucoma, open-angle
Open Angle Glaucoma
Intraocular Route of Administration
open-angle glaucoma, nos
Hypertonia
Intraocular
glaucoma

---
https://www.msss.gouv.qc.ca/professionnels/soins-et-services/protocoles-paramedics-soins-primaires/
2024
Canada
guideline
Clinical Study Protocol
allied health personnel
On Study
principal
Clinical Lot
Clinical Batch
Paramedic
primary health care
Ambulatory Care Facility
nursing
primary health care
Clinical Data
clinical protocols
Intervention for Congenital Heart Disease
Intervention
Primary Care
Usage

---
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions
https://recalls-rappels.canada.ca/fr/avis-rappel/ezetrol-ezetimibe-et-risques-lesions-hepatiques-origine-medicamenteuse-et-reactions
2024
false
false
false
Canada
French
English
pharmacovigilance note
Ezetimibe
Chemical and Drug Induced Liver Injury
Drug-Induced Liver Disease
drug hypersensitivity syndrome
stevens-johnson syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
canada
administration, oral
ezetimibe
anticholesteremic agents

---
https://www.has-sante.fr/jcms/p_3502273/fr/polystyrene-sulfonate-de-sodium-substipharm-polystyrene-sulfonate-de-sodium-hyperkaliemie
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
hyperkalemia
chelating agents
administration, oral
administration, rectal
polystyrene sulfonate
evaluation of the transparency committee
polystyrene sulfonic acid
polystyrenes
polystyrene sulfonic acid, homopolymer, sodium salt

---
https://minerva-ebp.be/FR/Article/2368
2024
Belgium
critical appraisal or critical reading
Kinked
dyspnea, nos
Effort
Patient
infectious disease, nos
dyspnea
Dyspnea, CTCAE
Person Initials
has patient
No Effort
physical exertion
Assistance
patients
ventilation, mechanical
masseur
Infection
European Union
Ehrlich Unit
What Month is it
rehabilitation
Adverse Event Associated with Infection
Post-Acute COVID-19 Syndrome
exertion, nos
mechanical ventilation, nos
Mechanical Ventilation
physical therapy specialty
respiration, artificial
counseling
Post-Acute Sequelae of COVID-19
physical therapists
Dyspnea

---
https://minerva-ebp.be/FR/Article/2370
2024
Belgium
critical appraisal or critical reading
knee prosthesis
Smartphone Application
supervision
Limburgish Language
Surgical Procedure was Curative Therapy
residence characteristics
Smartphone
Knee Joint
What Month is it
attention
rehabilitation
Efficacy Study
operative procedure, nos
prosthesis, nos
general surgery
domicile
Safety Issue Application
Surgical Procedure
Shawnee
safety
Management
efficiency
Prosthesis Device Component
Overdenture

---
https://www.has-sante.fr/jcms/p_3486120/fr/tibsovo-ivosidenib-cancer-des-voies-biliaires
2024
false
false
false
France
locally advanced or metastatic cholangiocarcinoma with an IDH1 R132 mutation
adult
treatment outcome
insurance, health, reimbursement
cholangiocarcinoma
Locally Advanced Cholangiocarcinoma
Metastatic Cholangiocarcinoma
administration, oral
antineoplastic agents
ivosidenib
evaluation of the transparency committee
ivosidenib

---
https://www.has-sante.fr/jcms/p_3487172/fr/botox-toxine-botulinique-type-a-blepharospasme-spasme-hemifacial-torticolis-spasmodique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
botulinum toxin
neuromuscular agents
evaluation of the transparency committee
hemifacial spasm
botulinum toxins, type A
blepharospasm
torticollis
Spasmodic Torticollis

---
https://www.has-sante.fr/jcms/p_3478093/fr/blincyto-blinatumomab-lal-en-echec-d-au-moins-2-traitements-avec-itk
2024
false
false
false
France
precursor cell lymphoblastic Leukemia-Lymphoma
leukemia, lymphocytic, acute, L2
B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
antineoplastic agents
blinatumomab
evaluation of the transparency committee
blinatumomab

---
https://www.has-sante.fr/jcms/p_3488172/fr/lynparza-olaparib-cancer-de-l-ovaire
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
olaparib
antineoplastic combined chemotherapy protocols
Bevacizumab/Olaparib Regimen
adult
Carcinoma, Ovarian Epithelial
Stage III Ovarian Cancer AJCC v6 and v7
Stage IV Ovarian Cancer AJCC v6 and v7
fallopian tube neoplasms
peritoneal neoplasms
administration, oral
evaluation of the transparency committee
olaparib

---
https://www.has-sante.fr/jcms/p_3481441/fr/ultibro-breezhaler-indacaterol/bromure-de-glycopyrronium-bronchopneumopathie-chronique-obstructive-bpco
2024
false
false
false
France
indacaterol
insurance, health, reimbursement
treatment outcome
drug combinations
indacaterol-glycopyrronium combination
adult
administration, inhalation
evaluation of the transparency committee
Glycopyrronium
pulmonary disease, chronic obstructive

---
https://www.has-sante.fr/jcms/p_3487169/fr/tagrisso-osimertinib-cancer-bronchique-non-a-petites-cellules-cbnpc
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
bronchial neoplasms
administration, oral
antineoplastic agents
osimertinib
adult
evaluation of the transparency committee
carcinoma, non-small-cell lung
osimertinib

---
https://www.has-sante.fr/jcms/p_3478084/fr/zepatier-elbasvir/grazoprevir-hepatite-c-chez-les-adolescents-a-partir-de-12-ans
2024
false
false
false
France
evaluation of the transparency committee
adolescence
Hepatitis C Virus
hepatitis C
viral hepatitis c
Elbasvir/Grazoprevir
adolescent
Zepatier
Autonomic Nervous System
Teenager
Twelve
elbasvir-grazoprevir drug combination
Adolescents
Adolescent
Hepatitis C Infection
Algeria

---
https://www.has-sante.fr/jcms/p_3478096/fr/kalydeco-ivacaftor-mucoviscidose
2024
false
false
false
France
infant
child
evaluation of the transparency committee
ivacaftor
cystic fibrosis
ivacaftor
Ivacaftor
Cystic Fibrosis
cystic fibrosis
kalydeco
ivacaftor

---
https://www.has-sante.fr/jcms/p_3478083/fr/sivextro-phosphate-de-tedizolid-infections-de-la-peau
2024
false
false
false
France
adolescent
evaluation of the transparency committee
tedizolid phosphate
Infection
tedizolid phosphate
infectious disease, nos
Phosphate
Claudin-6
Tiludronate Disodium
phosphates
Tedizolid Phosphate
Skin
Slice
Murine Skin
Ivermectin
Sivextro
skin diseases, infectious
Thaw
Go Skating

---
https://ansm.sante.fr/tableau-marr/inhibiteur-de-la-c1-esterase-humaine
2024
false
false
false
France
French
risk management
risk management
guidelines for drug use
guidelines for drug use
continuity of patient care
continuity of patient care
Human C1-Esterase Inhibitor
Human C1-Esterase Inhibitor
patients guideline
patients guideline

---
https://ansm.sante.fr/tableau-marr/ranibizumab-2
2024
false
false
false
France
French
Ranibizumab
byooviz
drug information
patient education handout
risk management
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
intravitreal injections

---
https://www.has-sante.fr/jcms/p_3488409/fr/libtayo-cemiplimab-cancer-bronchopulmonaire-non-a-petites-cellules-cbnpc
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
Antineoplastic Agents, Immunological
cemiplimab
antibodies, monoclonal, humanized
antineoplastic combined chemotherapy protocols
adult
platinum compounds
PD-L1 Positive
evaluation of the transparency committee
carcinoma, non-small-cell lung
cemiplimab

---
https://www.has-sante.fr/jcms/p_3488284/fr/caspofungine-tillomed-caspofungine-antimycotique-a-usage-systemique
2024
false
false
false
France
drugs, generic
infusions, intravenous
caspofungin
evaluation of the transparency committee
Caspofungin
antifungal agents

---
https://www.has-sante.fr/jcms/p_3487904/fr/xolair-omalizumab-polypose-naso-sinusienne
2024
false
false
false
France
nasal polyps
Polyp of nasal cavity and/or nasal sinus (disorder)
evaluation of the transparency committee
xolair
Omalizumab
Polyposis
Omalizumab

---
https://www.has-sante.fr/jcms/p_3488174/fr/nplate-romiplostim-thrombopenie-immunologique-primaire-pti-refractaire-aux-autres-traitements
2024
false
false
false
France
Primary Immune Thrombocytopenia
evaluation of the transparency committee
nplate
principal
Romiplostim
Immunotherapy
romiplostim
Refractory
thrombocytopenia due to immune destruction, nos
Primary Refractory
romiplostim
idiopathic thrombocytopenic purpura, nos
Other Therapy
Immune
Immunology
thrombocytopenia
purpura, thrombocytopenic, idiopathic
immunology

---
https://www.has-sante.fr/jcms/p_3289276/fr/grande-precarite-et-troubles-psychiques-intervenir-aupres-des-personnes-en-situation-de-grande-precarite-presentant-des-troubles-psychiques
2024
false
false
false
France
mentally ill persons
poverty
Ill-Housed Persons
health services accessibility
healthcare disparities
interdisciplinary communication
Psychosocial Intervention
public health guidelines
mental disorders

---
https://www.has-sante.fr/jcms/p_3488415/fr/jemperli-dostarlimab-cancer-de-l-endometre
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
dostarlimab
adult
mismatch repair deficient/microsatellite instability-high recurrent or advanced endometrial cancer that has progressed
Advanced Endometrial Carcinoma
Recurrent Endometrial Carcinoma
evaluation of the transparency committee
endometrial neoplasms
dostarlimab

---
https://www.has-sante.fr/jcms/p_3488641/fr/closalis-calcipotriol/betamethasone-psoriasis
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
adult
calcipotriol, combinations
administration, cutaneous
ointments
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug)
evaluation of the transparency committee
psoriasis

---
https://esante.gouv.fr/produits-services/repertoire-ror
France
directory
directory
Offer
Offer
Resource Guide
Resource Guide
directories as topic
directories as topic
social support
social support
socialism
socialism
Research Resource
Research Resource
Social
Social
measles-mumps-rubella vaccine
measles-mumps-rubella vaccine
health resources
health resources
Means
Means

---
https://publications.msss.gouv.qc.ca/msss/document-003676/
2024
Canada
guidelines for drug use
Transference
Ambulatory Care Facility
Usage
Clinical Data
Countertransference
Transfer, Psychology
Healthcare Activity
Intervention for Congenital Heart Disease
Clinical Batch
clinical protocols
Healthcare
Clinical Lot
Transfer
nursing
Care
On Study
Clinical Study Protocol
How True Feel Carefree Right Now
Intervention
Transfer Ability
Stooping

---
https://www.reiso.org/articles/themes/handicaps/11916-handicaps-et-addictions-quelles-interfaces
2024
Switzerland
popular works
Disabled
Disabled Population
behavior, addictive
disabled persons
Addiction
handicap
dependent drug abuse

---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-liees-au-travail/maladies-a-caractere-professionnel/documents/rapport-synthese/priorisation-des-couples-maladie-facteur-de-risque-pour-l-estimation-du-fardeau-environnemental-et-professionnel-de-la-maladie-en-france
2024
France
technical report
Health Care Professional Promotional Material
Risk Estimate
appraiser
Disease Steps Clinical Classification
france
tularemia
CHFR Gene
family characteristics
risk factors
tularemia, nos
Professional Occupation
environmental illness
risk factor
couples
risk assessment
Couple
Disease Free
Environmental Risk Factor
Disease Object
cost of illness
occupational diseases
hazardous substances
Coupler Device
Burden
No Evidence of Coronary Artery Disease

---
https://ansm.sante.fr/tableau-marr/susoctocog-alfa
2024
false
false
false
France
French
risk management
Susoctocog Alfa
medication errors
guidelines for drug use
drug dosage calculations
video recording

---
https://www.has-sante.fr/jcms/p_3490839/fr/cufence-trientine-dichlorhydrate-maladie-de-wilson
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
chelating agents
trientine
adult
adolescent
child
evaluation of the transparency committee
trientine hydrochloride
hepatolenticular degeneration
trientine

---
https://www.has-sante.fr/jcms/p_3490841/fr/reblozyl-luspatercept-anemie-associee-a-une-beta-thalassemie
2024
false
false
false
France
evaluation of the transparency committee
beta-Thalassemia
luspatercept

---
https://www.has-sante.fr/jcms/p_3490834/fr/trodelvy-sacituzumab-govitecan-cancer-du-sein
2024
false
false
false
France
adult
treatment outcome
insurance, health, reimbursement
infusions, intravenous
sacituzumab govitecan
HER2/Neu Negative
Hormone Receptor Positive
evaluation of the transparency committee
breast neoplasms
sacituzumab govitecan

---
https://www.has-sante.fr/jcms/p_3490824/fr/crysvita-burosumab-hypophosphatemie-liee-a-l-x
2024
false
false
false
France
child
adolescent
treatment outcome
insurance, health, reimbursement
rickets, X-Linked hypophosphatemic
burosumab
injections, subcutaneous
antibodies, monoclonal, humanized
evaluation of the transparency committee
burosumab
familial hypophosphatemic rickets
X-Linked Dominant Hypophosphatemic Rickets

---
https://www.has-sante.fr/jcms/p_3490837/fr/esbriet-pirfenidone-fibrose-pulmonaire-idiopathique-fpi-severe
2024
false
false
false
France
evaluation of the transparency committee
Borg Category-Ratio 10 Perceived Exertion Score 5
Epidermal cGVHD Score 4
fibrosis of lung, nos
Severe Adverse Event
Pirfenidone
idiopathic pulmonary fibrosis
severe
esbriet
Severe Dysplasia
pirfenidone
unknown (origin)
Severe Hallucination
Idiopathic Pulmonary Fibrosis
Severe Extremity Pain
Intensity and Distress 5
pirfenidone

---
https://ansm.sante.fr/tableau-marr/mecasermine
2024
false
false
false
France
French
risk management
mecasermin
mecasermin
mecasermin
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
mecasermin
hypoglycemia
injections, subcutaneous

---
https://www.societefrancaisedesanteautravail.fr/_docs/actus/69/Fichier-69-1-093837.pdf
2024
France
practice guideline
occupation, nos
Health Status
health status
CDISC SDTM Environmental Setting Terminology
occupational health
workplace
Occupational Health
Patient Observation
nurse administrators
Drinking Status
disease management
EXT1 wt Allele
guideline adherence

---
https://www.louvainmedical.be/fr/article/adapter-la-formation-des-futures-soignantes-pour-les-preparer-aux-enjeux-du-developpement
2024
Belgium
journal article
Preparation
Transition Mutation
future
Sequencing Adapter
Development Batch
habilitation
Sustainable Development
Human Activity Profile
rehabilitation
Adaptation
has provider
Nucleotide Transition Abnormality
Adaptive Study Design Indicator
Adjustment
Development Lot
forecasting
adaptation, nos
Change
caregivers
Transition
Maturation
Training

---
https://ansm.sante.fr/tableau-acces-derogatoire/itraconazole
2024
false
false
false
France
French
itraconazole
guidelines for drug use
administration, oral
tinea
child
microsporum
antifungal agents
itraconazole
continuity of patient care

---
https://www.unisante.ch/fr/formation-recherche/recherche/publications/raisons-sante/raisons-sante-353
2024
Switzerland
technical report
Treating
opiate agonist, nos
Disposition Start Time
Retreatment Following Intervention for Kawasaki Disease
Treat
retreatment
Biomaterial Treatment
Tray
Trait
Tray Dosing Unit
During Treatment
Treatment Study
postman
duration
analgesics, opioid
Township
Treatment
Therapy Object
Treatment Epoch
On Treatment
No Treatment for Diabetes
Opioid
opioids
GDC Treatment Frequency Terminology
Duration of Therapy

---
https://www.has-sante.fr/jcms/p_3493096/fr/prise-en-charge-de-la-retinopathie-du-premature
2024
France
practice guideline
Chronic Disease
retinopathy
chronic disease
Retinopathy of Prematurity, AE
Retinopathy of Prematurity
disease management
Guide Device
chronic disease, nos
retinopathy of prematurity
retrolental fibroplasia
Charge
infant, premature, diseases
Handbook

---
https://ansm.sante.fr/informations-de-securite/pseudoephedrine-risques-de-syndrome-dencephalopathie-posterieure-reversible-pres-et-de-syndrome-de-vasoconstriction-cerebrale-reversible-rcvs
2024
false
false
false
France
French
pharmacovigilance note
pseudoephedrine
Posterior reversible encephalopathy syndrome (disorder)
posterior leukoencephalopathy syndrome
Reversible cerebral vasoconstriction syndrome (disorder)
cerebrovascular disorders
pseudoephedrine
administration, oral
nasal decongestants
pseudoephedrine, combinations

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/soutien-aux-pratiques-cliniques-et-organisationnelles-dans-les-services-de-readaptation-pour-les-jeunes-en-difficulte-dadaptation-ages-de-10-ans-et-plus.html
2024
Canada
technical report
Adjustment
Clinical Service
Adaptive Study Design Indicator
Youth
adolescent
rehabilitation
No Support Needed
Have Other Problem
habilitation
Rehabilitation
rehabilitation therapy, nos
Support
Human Activity Profile
Difficult
adaptation, nos
rehabilitation centers
Adaptation
Can Do Without Any Difficulty
hospitals, proprietary

---
https://ansm.sante.fr/actualites/decision-du-13-02-2024-cadre-de-prescription-compassionnelle-de-tibsovo-ivosidenib-250mg-comprime-pellicule
https://ansm.sante.fr/tableau-acces-derogatoire/ivosidenib
2024
false
false
false
France
French
drug information
administration, oral
ivosidenib
adult
glioma
guidelines for drug use
continuity of patient care
Unresectable Low Grade Glioma
Refractory Low Grade Glioma
IDH1 Gene Mutation
ivosidenib

---
https://cps.ca/fr/documents/position/pharmacotherapie-genes-medicaments-psychoactifs
2024
Canada
practice guideline
genes
Adolescents
Gene
Offspring
adolescent
drug, nos
Nutritional Support
Pharmacotherapy
Medication
Pharmacologic Substance
adolescence
child, nos
child
Child
Mathematical Operator
drug therapy
pharmaceutical preparations
Teenager
Drug Therapy
GDC Therapeutic Agent Terminology
Adolescent

---
https://minerva-ebp.be/Theme/Analysis/851
2024
Belgium
critical appraisal or critical reading
Clinical Effectiveness
Dispense
cost effectiveness
sleep, nos
Health Care Provider
therapy, nos
sleep
Certified IRB Professional
Cost-Benefit analysis
Treatment Efficacy
NURF
Clinical Relevance
Nuclear Receptor Subfamily 4 Group A Member 1
Papaverine Hydrochloride
primary health care
principal
Sleep Efficiency
Provider Domain
health personnel
nursing
Enterostomal Therapy Nurse Specialist
primary health care
Costs
Comprehensive Score for Financial Toxicity
Dispensing
Primary Care
Restriction

---
https://minerva-ebp.be/Theme/Analysis/853
2024
Belgium
critical appraisal or critical reading
patients
What Month is it
Assistance
American Stop Smoking Intervention for Cancer Prevention
Heart
heart
Cardiac
homemaker services
domicile
heart, nos
therapy, nos
Papaverine Hydrochloride
has patient
self care
Patient
Metacognition
counseling

---
https://minerva-ebp.be/FR/Article/2371
2024
Belgium
critical appraisal or critical reading
Ankyloglossia
tongue tie
Until Effective
What Month is it
myofunctional therapy
Papaverine Hydrochloride
Ankyloglossia
therapy, nos

---
https://ordomedic.be/fr/avis/deontologie/personnes-vulnerables/attestation-par-le-m%C3%A9decin-g%C3%A9n%C3%A9raliste-de-lexistence-dune-contre-indication-m%C3%A9dicale-%C3%A0-ladoption.
2024
Belgium
scientific and technical information
certification
general practice
Primary Care Provider
Medical Contraindication
contraindication to
adoption
Certification
general practitioners
Adopted Son
adoption, nos
Contraindications

---
https://www.has-sante.fr/jcms/p_3505761/fr/retsevmo-selpercatinib-cancer-bronchique-non-a-petites-cellules
2024
false
false
false
France
bronchial neoplasms
adult
treatment outcome
insurance, health, reimbursement
antineoplastic agents
administration, oral
selpercatinib
package leaflet
summary of product characteristics
guidelines for drug use
advanced RET fusion-positive non-small cell lung cancer
RET Fusion Positive
carcinoma, non-small-cell lung
Advanced Lung Non-Small Cell Carcinoma
evaluation of the transparency committee
selpercatinib
carcinoma, non-small-cell lung

---
https://www.has-sante.fr/jcms/p_3470375/fr/camzyos-mavacamten-cardiomyopathie-hypertrophique-obstructive
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
mavacamten
administration, oral
New York Heart Association Class II
New York Heart Association Class III
adult
symptomatic (New York Heart Association, NYHA, class II-III) obstructive hypertrophic cardiomyopathy (oHCM)
evaluation of the transparency committee
cardiomyopathy, hypertrophic
mavacamten
Cardiomyopathy, Hypertrophic Obstructive

---
https://www.has-sante.fr/jcms/p_3503160/fr/zilbrysq-zilucoplan-sodique-myasthenie
2024
false
false
false
France
zilucoplan
treatment outcome
insurance, health, reimbursement
myasthenia gravis, generalized
myasthenia gravis
adult
Anti-acetylcholine receptor antibody positivity
evaluation of the transparency committee
zilucoplan
myasthenia gravis

---
https://www.has-sante.fr/jcms/p_3505740/fr/lojuxta-lomitapide-hypercholesterolemie-familiale-homozygote
2024
false
false
false
France
Lomitapide Mesylate
Homozygous Familial Hypercholesterolemia
child
adolescent
evaluation of the transparency committee
lomitapide
Lomitapide Mesylate
mesylates

---
https://www.reiso.org/articles/themes/vieillesse/12246-participation-active-pour-le-vieillissement-en-sante
2024
Switzerland
journal article
Password Aging
activator appliances
health
Participation
aging
Aging
aging
activir
Activation

---
https://ansm.sante.fr/actualites/avis-de-lansm-du-11-03-2024-sur-le-medicament-keytruda-dans-le-cadre-dune-demande-daap
2024
false
false
false
France
French
treatment outcome
pembrolizumab
Antineoplastic Agents, Immunological
drug information
Resectable Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
neoplasm recurrence, local
risk
pembrolizumab

---
https://ansm.sante.fr/tableau-marr/belatacept
2024
false
false
false
France
French
guidelines for drug use
guidelines for drug use
risk management
risk management
BELATACEPT
BELATACEPT
immunosuppressive agents
immunosuppressive agents
infusions, intravenous
infusions, intravenous
belatacept
belatacept
patient education handout
patient education handout
Infusion-Related Reaction
Infusion-Related Reaction
infusions, intravenous
infusions, intravenous

---
https://ansm.sante.fr/tableau-marr/sutimlimab
2024
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout

---
https://ansm.sante.fr/actualites/progestatifs-et-risque-de-meningiomes-intracraniens-le-bmj-publie-une-etude-epidemiologique-francaise
2024
false
false
false
France
French
pharmacovigilance note
epidemiologic studies
france
meningioma
meningioma
medroxyprogesterone acetate
risk assessment
Product containing only levonorgestrel in intrauterine dose form (medicinal product form)
levonorgestrel
injections, intramuscular
plastic iud with progestogen
administration, intravaginal
progestins
intrauterine devices
medroxyprogesterone

---
https://ansm.sante.fr/tableau-marr/glucagon
2024
false
false
false
France
French
guidelines for drug use
risk management
glucagon
glucagon
administration, intranasal
patient education handout

---
https://ansm.sante.fr/tableau-acces-derogatoire/blenrep
2024
false
false
false
France
French
infusions, intravenous
drug information
antibodies, monoclonal, humanized
belantamab mafodotin
Antineoplastic Agents, Immunological

---
https://www.has-sante.fr/jcms/p_3505841/fr/ventizolve-naloxone-antidote-des-surdoses-aux-opioides
2024
false
false
false
France
administration, intranasal
treatment outcome
insurance, health, reimbursement
Naloxone Hydrochloride Dihydride
narcotic antagonists
emergency treatment
adult
naloxone
evaluation of the transparency committee
Opiate Overdose
naloxone
antidotes

---
https://ansm.sante.fr/tableau-marr/dronedarone
2024
false
false
false
France
French
risk management
continuity of patient care
Dronedarone
Dronedarone
dronedarone
administration, oral
guidelines for drug use
patient education handout
atrial fibrillation
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
anti-arrhythmia agents
anti-arrhythmia agents

---
https://www.has-sante.fr/jcms/p_3471694/fr/orkambi-lumacaftor/ivacaftor-mucoviscidose
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
lumacaftor, ivacaftor drug combination
drug combinations
ivacaftor
lumacaftor
ivacaftor and lumacaftor
infant
administration, oral
evaluation of the transparency committee
cystic fibrosis

---
https://ansm.sante.fr/tableau-marr/crizotinib
2024
false
false
false
France
French
patients guideline
patient education handout
drug information
risk management
Crizotinib
Crizotinib
continuity of patient care
crizotinib
vision disorders
adult
child

---
https://www.cfp.ca/content/70/4/e47
2024
Canada
journal article
equipment
Adjustment
Adaptation
habilitation
Single Group Study
rehabilitation
focus groups
patient care team
Adaptive Study Design Indicator
nursing
adaptation, nos
Healthcare
Healthcare Activity
Sequencing Adapter
How True Feel Carefree Right Now
Care
Change
Scientific Equipment
Human Activity Profile

---
https://ansm.sante.fr/actualites/modification-des-conditions-de-prescription-et-de-delivrance-de-certaines-biotherapies-utilisees-dans-le-traitement-de-maladies-inflammatoires-chroniques
2024
false
false
false
France
French
guidelines for drug use
injections, subcutaneous
Interleukin Inhibitors
immunosuppressive agents
biological therapy
general practice
antibodies, monoclonal
immunoconjugates
Tumor Necrosis Factor Inhibitors
Chronic inflammatory disorder (disorder)

---
https://minerva-ebp.be/Theme/Analysis/860
2024
Belgium
critical appraisal or critical reading
What Month is it
Packaging Case
BCAR1 wt Allele
Catenin Delta-1
musculoskeletal manipulations
vertebra, nos
Nonspecific Heart Murmur
Be
Story
Breast Cancer Anti-Estrogen Resistance Protein 1
snacks
Vertebral
Interleukin
Israel
Case
manual therapies
Illinois
achievement
CTNND1 wt Allele
low back pain
Case Dosing Unit
True Case Status
lumbago
Coronavirus Anxiety Scale
Targeted Therapy
therapy, nos
Nonspecific
non-specific
No Cases Transmission Pattern
Lower Back Pain

---
https://www.has-sante.fr/jcms/p_3506437/fr/rubraca-rucaparib-cancer-de-l-ovaire
2024
France
evaluation of the transparency committee
Rubraca
neoplasm, malignant
cancer
rucaparib
rucaparib
ovarian neoplasms
Rucaparib Camsylate
Rucaparib
ovary
Ovarian Carcinoma

---
https://www.has-sante.fr/jcms/p_3506440/fr/repatha-evolocumab-hypercholesterolemie
2024
France
evaluation of the transparency committee
repatha
Hypercholesterolemia
hypercholesterolemia
evolocumab
Evolocumab
evolocumab
hypercholesterolemia, nos

---
https://www.has-sante.fr/jcms/p_3508486/fr/uvedose-cholecalciferol-carence-en-vitamine-d
2024
France
evaluation of the transparency committee
Vitamin D3
vitamin d deficiency, nos
Vitamin D3 Measurement
Vitamin D Deficiency
vitamin d deficiency
Cholecalciferol
vitamin d3
cholecalciferol

---
https://www.has-sante.fr/jcms/p_3508868/fr/acide-tranexamique-tillomed-acide-tranexamique-antifibrinolytique
2024
France
evaluation of the transparency committee
Tranexamic Acid
antifibrinolytic agents
acid, nos
tranexamic acid

---
https://www.cochrane.org/fr/CD004871/BACK_massage-pour-les-douleurs-cervicales
2024
false
United Kingdom
France
French
pain management
review of literature
neck pain
treatment outcome
massage
french abstract

---
https://www.cochrane.org/fr/CD015432/SYMPT_quels-sont-les-benefices-et-les-risques-de-libuprofene-dans-la-prise-en-charge-de-la-douleur-apres
2024
United Kingdom
review of literature
french abstract
pain
child, nos
Pain Therapy
During or After
Status Post
ibuprofen
pain management
risks and benefits
Surgical Procedure
pain, nos
operative procedure, nos
child
What Month is it
Child Relation
surgical procedures, operative
Ibuprofen
risk-taking
risk assessment
Operation
ibuprofen
Child Individual

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1368
2024
France
public health guidelines
Ventilation
Neither Agree or Disagree
administration, topical
Theophylline
Localized Disease
hygiene
Location of Oral Residue Following Swallowing
attentiveness
Location of Pharyngeal Residue Following Swallowing
risk
Relative Value
judgment
Local-Regional
Anatomic Site
ventilation
Usage
epidemics
ventilation, nos
Locally
with cleaniless
Epidemic Disorder
Usually Need Help from Another Person for Hygiene

---
https://www.vie-publique.fr/rapport/293097-bien-vivre-et-vieillir-dans-lautonomie-domicile-rapport-du-hcfea
2024
France
technical report
aged, 80 and over
Unresponsive
Aspirations, Psychological
Reside
Elderly
habilitation
independent living
health services needs and demand
Need
aspirator, nos
aging
Sequencing Adapter
rehabilitation
elderly person, nos
Aging
Adaptive Study Design Indicator
adaptation, nos
Human Activity Profile
pulmonary aspiration, nos
aging in place
Healthy Aging
personal autonomy
needs
Adaptation
aged
Autonomic Nervous System
frail elderly
Change
Important that I Look Good
Aspiration
Adjustment

---
https://www.has-sante.fr/jcms/p_3497014/fr/dovato-dolutegravir/lamivudine-antiretroviraux
2024
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
lamivudine
dolutegravir sodium
dolutegravir
Dolutegravir Sodium/Lamivudine
hiv infections
HIV-1
adult
adolescent
lamivudine and dolutegravir
administration, oral
evaluation of the transparency committee
anti-retroviral agents

---
https://www.has-sante.fr/jcms/p_3497011/fr/jardiance-empagliflozine-maladie-renale-chronique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
empagliflozin
drug therapy, combination
administration, oral
Sodium-Glucose Transporter 2 Inhibitors
chronic kidney diseases
evaluation of the transparency committee
empagliflozin

---
https://www.has-sante.fr/jcms/p_3492882/fr/alvesco-ciclesonide-asthme
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
glucocorticoids
administration, inhalation
ciclesonide
evaluation of the transparency committee
asthma
ciclesonide

---
https://www.has-sante.fr/jcms/p_3497026/fr/mircera-methoxy-polyethylene-glycol-epoetine-beta-anemie-symptomatique-associee-a-l-insuffisance-renale-chronique-chez-les-enfants-ages-de-3-mois-a-moins-de-18-ans
2024
false
false
false
France
infant
adolescent
treatment outcome
insurance, health, reimbursement
hematinics
methoxy polyethylene glycol-epoetin beta
Anemia of chronic renal failure (disorder)
evaluation of the transparency committee
continuous erythropoietin receptor activator
polyethylene glycols
anemia
erythropoietin
methoxy polyethylene glycol-epoetin beta
renal insufficiency, chronic
child

---
https://ansm.sante.fr/actualites/difficultes-dapprovisionnement-en-rythmodan-250-mg-lp-ce-medicament-doit-etre-remplace-par-rythmodan-100-mg
2024
false
false
false
France
French
guideline
guideline
drug information
drug information
disopyramide
disopyramide
Disopyramide Phosphate
Disopyramide Phosphate
administration, oral
administration, oral
anti-arrhythmia agents
anti-arrhythmia agents
patient education handout
patient education handout

---
https://ansm.sante.fr/actualites/difficultes-dapprovisionnement-en-methylphenidate-lansm-publie-des-recommandations-pour-les-pharmaciens
2024
false
false
false
France
French
drug information
guideline
methylphenidate
methylphenidate
patient education handout
administration, oral

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/rythmodan-250-mg-a-liberation-prolongee-comprime-enrobe-disopyramide-phosphate-de
2024
false
false
false
France
French
disopyramide
disopyramide
administration, oral
administration, oral
drug information
drug information

---
https://www.has-sante.fr/jcms/p_3495477/fr/axs-vecta
2024
France
health technology assessment
pulmonary aspiration, nos
Aspiration
Respiratory Tract Aspiration
catheter, nos
catheterization
Aspiration, CTCAE
suction
Catheter Device
Catheter

---
https://www.has-sante.fr/jcms/p_3495480/fr/axs-catalyst
2024
France
health technology assessment
Catheter Device
Catalyst
suction
catheterization
Catheter
Aspiration, CTCAE
Respiratory Tract Aspiration
Aspiration
catheter, nos
pulmonary aspiration, nos

---
https://www.has-sante.fr/jcms/p_3497065/fr/visipaque-iodixanol-produit-de-contraste-iode
2024
false
false
false
France
iodixanol
-
-
evaluation of the transparency committee
iodine
iodixanol
contrast media

---
https://www.cochrane.org/fr/CD001552/NEUROMUSC_traitement-chirurgical-ou-non-chirurgical-du-syndrome-du-canal-carpien
2024
United Kingdom
review of literature
french abstract
carpal tunnel syndrome
Non-Surgical
root canal therapy
Raw
carpal tunnel syndrome
carpal tunnel syndrome
Carpal Tunnel Syndrome

---
https://www.has-sante.fr/jcms/p_3496824/fr/redonne
2024
France
health technology assessment
Therapeutic
SHOX Gene
Treatment
adulthood
Extraction
therapeutic uses
Therapeutic Procedure
Legal Adult
shoes
Prolonged Release Mechanism of Action
long
therapeutics
adult
Usage
Screening Observation Carried Forward Imputation Technique

---
https://www.has-sante.fr/jcms/p_3497167/fr/penumbra-3maxc
2024
France
health technology assessment
catheter, nos
pulmonary aspiration, nos
Catheter
suction
Respiratory Tract Aspiration
Aspiration, CTCAE
Aspiration
Catheter Device
catheterization

---
http://beh.santepubliquefrance.fr/beh/2024/5/2024_5_1.html
2024
France
journal article
Convenient
france
French Language
Program
french
Screening for Colorectal Cancer
organization
cancer screening
Schedule
malignant neoplasm colon/rectum
screening for cancer
early detection of cancer
French Catheter Gauge
Organization
Participation
Respect
Scheduled
Colorectal Cancer
Version
appraiser
colorectal neoplasms
mass screening
Estimate
Statistical Estimation

---
https://www.has-sante.fr/jcms/p_3498133/fr/penumbra-jet7
2024
France
health technology assessment
Catheter Device
catheterization
Respiratory Tract Aspiration
catheter, nos
pulmonary aspiration, nos
Catheter
Aspiration, CTCAE
suction
Aspiration

---
https://www.has-sante.fr/jcms/p_3498136/fr/penumbra-red
2024
France
health technology assessment
Catheter Device
Aspiration, CTCAE
Catheter
suction
catheter, nos
Aspiration
catheterization
pulmonary aspiration, nos
Respiratory Tract Aspiration

---
https://www.has-sante.fr/jcms/p_3498139/fr/penumbra-jetd
2024
France
health technology assessment
Catheter Device
catheterization
Respiratory Tract Aspiration
Aspiration
catheter, nos
pulmonary aspiration, nos
Catheter
suction
Aspiration, CTCAE

---
https://www.has-sante.fr/jcms/p_3498143/fr/penumbra-ace
2024
France
health technology assessment
carcinoembryonic antigen
Catheter
Cyclophosphamide/Doxorubicin
Cisplatin/Cytarabine/Etoposide
pulmonary aspiration, nos
Angiotensin Converting Enzyme Measurement
Catheter Device
carcinoembryonic antigen
catheter, nos
Aspiration, CTCAE
catheterization
Aspiration
Angiotensin-Converting Enzyme
ACE Gene
suction
Respiratory Tract Aspiration

---
https://www.has-sante.fr/jcms/p_3498124/fr/kevzara-sarilumab-polyarthrite-rhumatoide
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
sarilumab
drug therapy, combination
methotrexate
adult
injections, subcutaneous
evaluation of the transparency committee
arthritis, rheumatoid
sarilumab

---
https://www.has-sante.fr/jcms/p_3498146/fr/myozyme-alglucosidase-alfa-maladie-de-pompe-deficit-en-glucosidase-acide
2024
false
false
false
France
GAA protein, human
adult
adolescent
child
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
infusions, intravenous
alglucosidase alfa
glycogen storage disease type II, infantile
adult glycogen storage disease type II
Glycogen storage disease type II late onset (disorder)
evaluation of the transparency committee
glycogen storage disease type ii
alglucosidase alfa

---
https://www.has-sante.fr/jcms/p_3498568/fr/lovenox-enoxaparine-sodique-traitement-antithrombotique
2024
false
false
false
France
evaluation of the transparency committee
evaluation of the transparency committee
enoxaparin
enoxaparin
antithrombotic agents
antithrombotic agents
Treat
Treat
During Treatment
During Treatment
No Treatment for Diabetes
No Treatment for Diabetes
Therapy Object
Therapy Object
fibrinolytic agents
fibrinolytic agents
Treatment Epoch
Treatment Epoch
Treatment
Treatment
Biomaterial Treatment
Biomaterial Treatment
On Treatment
On Treatment
Thrombolytic Agent
Thrombolytic Agent
GDC Treatment Frequency Terminology
GDC Treatment Frequency Terminology
Treatment Study
Treatment Study
Enoxaparin Sodium
Enoxaparin Sodium
lovenox
lovenox

---
https://www.has-sante.fr/jcms/p_3498127/fr/dificlir-fidaxomicine-infection-a-clostridium-difficile
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
fidaxomicin
tablets
adult
anti-bacterial agents
time
evaluation of the transparency committee
Fidaxomicin
clostridium infections
Clostridium difficile Infections

---
https://www.has-sante.fr/jcms/p_3473151/fr/fiche-bum-dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2024
false
false
false
France
dupilumab
benralizumab
mepolizumab
tezepelumab
other systemic drugs for obstructive airway diseases
adult
child
drug therapy, combination
Severe persistent asthma (disorder)
adolescent
Respiratory corticosteroid (substance)
adrenergic beta-2 receptor agonists
guidelines for drug use
Omalizumab
asthma

---
https://www.has-sante.fr/jcms/p_3498562/fr/adtralza-tralokinumab-dermatite-atopique-chez-l-adulte-et-l-adolescent-a-partir-de-12-ans
2024
false
false
false
France
tralokinumab
injections, subcutaneous
adolescent
adult
dermatitis, atopic
Adult atopic dermatitis (disorder)
evaluation of the transparency committee
tralokinumab

---
https://www.inspq.qc.ca/publications/3464
2024
Canada
technical report
Respect
appraiser
reticulum
COVID-19
population
Amplifier Device
Evaluation Method
General Population
COVID-19 Infection
Number of Cases
protestantism
Estimate
amplifiers, electronic
quebec
snacks
general practitioners
Enhancer
Statistical Estimation
Device Evaluation Method
evaluation studies as topic

---
https://www.has-sante.fr/jcms/p_3415645/fr/qinlock-ripretinib-tumeurs-stromales-gastro-intestinales
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Advanced Gastrointestinal Stromal Tumor
Refractory Malignant Gastrointestinal Stromal Tumor
antineoplastic agents
ripretinib
administration, oral
evaluation of the transparency committee
gastrointestinal stromal tumors
ripretinib

---
https://www.has-sante.fr/jcms/p_3468175/fr/imfinzi-durvalumab-cancer-des-voies-biliaires
2024
false
false
false
France
Cisplatin/Durvalumab/Gemcitabine Regimen
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
cisplatin
Gemcitabine
Unresectable Biliary Tract Carcinoma
Metastatic Biliary Tract Carcinoma
neoplasm metastasis
Antineoplastic Agents, Immunological
durvalumab
adult
guidelines for drug use
evaluation of the transparency committee
biliary tract cancer
biliary tract neoplasms
durvalumab

---
https://www.has-sante.fr/jcms/p_3498750/fr/keytruda-pembrolizumab-carcinome-a-cellules-renales
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
antineoplastic combined chemotherapy protocols
clear cell renal cell carcinoma
Lenvatinib/Pembrolizumab Regimen
Advanced Clear Cell Renal Cell Carcinoma
infusions, intravenous
Antineoplastic Agents, Immunological
pembrolizumab
evaluation of the transparency committee
pembrolizumab
carcinoma, renal cell

---
https://ansm.sante.fr/tableau-marr/tocilizumab-1
2024
false
false
false
France
French
risk management
tocilizumab
infusions, intravenous
injections, subcutaneous
guidelines for drug use
tocilizumab
tocilizumab
patient education handout
continuity of patient care
tocilizumab

---
https://ansm.sante.fr/tableau-marr/sarilumab
2024
false
false
false
France
French
risk management
continuity of patient care
drug information
injections, subcutaneous
antibodies, monoclonal, humanized
sarilumab
patients guideline

---
https://www.cma.ca/fr/dernieres-mises-jour/contrer-desinformation-sante-professionnels-professionnelles-sante-parmi-sources-dinformation-plus
2024
Canada
scientific and technical information
Subsource
No Information Available
health personnel
health
Disinformation
data collection
probing, nos
Health Care Professional
catheterization
Information Sources
Health Professional
misinformation
consumer health information

---
https://www.has-sante.fr/jcms/p_3499784/fr/prolastin-alpha-1-antitrypsine-humaine-deficit-en-alpha-1-antitrypsine
2024
false
false
false
France
insurance, health, reimbursement
alfa1 antitrypsin
alpha 1-Antitrypsin
alpha 1-antitrypsin deficiency
Product containing only human alpha1 proteinase inhibitor in parenteral dose form (medicinal product form)
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3499781/fr/ferinject-carboxymaltose-ferrique-carence-martiale
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
iron, parenteral preparations
injections, intravenous
infusions, intravenous
ferric carboxymaltose
ferric compounds
Iron Deficiencies
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3499775/fr/sialanar-bromure-de-glycopyrronium-sialorrhee-severe
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
Glycopyrronium
glycopyrrolate
sialorrhea
glycopyrronium
nervous system diseases
chronic disease
child
adolescent
administration, oral
pharmaceutical solutions
evaluation of the transparency committee

---
https://cps.ca/fr/documents/position/les-objectifs-des-echanges-sur-les-soins-et-de-la-planification-prealable-des-soins-chez-les-patients-dage-pediatrique-atteints-dune-maladie-grave
2024
Canada
practice guideline
Abnormal Involuntary Movement Scale Clinical Classification
Pediatric Disorder
age, nos
Questionnaire Not Completed Due to Patient Illness
Patient Care
goals
advance directives
patient care
Advanced Glycation End Product
pediatrics
Pediatricians
pediatrician
aged
Subject Age
toxic diffuse goiter
critical illness
has patient
Plan
patient care planning
Graves Disease
communication
disease
Elderly

---
https://www.has-sante.fr/jcms/p_3500260/fr/livmarli-maralixibat-syndrome-d-alagille
2024
false
false
false
France
Cholestatic pruritus (disorder)
treatment outcome
insurance, health, reimbursement
infant
child
administration, oral
pharmaceutical solutions
maralixibat chloride
Maralixibat Chloride
cholestatic pruritus in Alagille syndrome
evaluation of the transparency committee
alagille syndrome
maralixibat

---
https://ansm.sante.fr/tableau-marr/agalsidase-beta
2023
false
false
false
France
French
risk management
agalsidase beta
guidelines for drug use
patients guideline
infusions, intravenous
enzyme replacement therapy
fabry disease
continuity of patient care
home health nursing

---
https://ansm.sante.fr/tableau-marr/methoxyflurane
2023
false
false
false
France
French
risk management
methoxyflurane
administration, inhalation
guidelines for drug use
methoxyflurane
methoxyflurane
Drug-Related side effects and adverse reactions
emergency treatment
pain
wounds and injuries
Post-traumatic pain

---
https://ansm.sante.fr/tableau-marr/asfotase-alfa
2023
false
false
false
France
French
risk management
guidelines for drug use
asfotase alfa
asfotase alfa
self administration
patients guideline
child
injections, subcutaneous
enzyme replacement therapy
asfotase alfa
hypophosphatasia

---
https://ansm.sante.fr/tableau-marr/filgotinib
2023
false
false
false
France
French
guidelines for drug use
risk management
filgotinib
administration, oral
patient education handout
filgotinib
filgotinib
Janus Kinase Inhibitors
adult
aged
pregnancy
breast feeding
Janus Kinase Inhibitors
arthritis, rheumatoid

---
https://ansm.sante.fr/tableau-marr/propranolol
2023
false
false
false
France
French
risk management
propranolol
propranolol hydrochloride
administration, oral
guidelines for drug use
patients guideline
child
Drug-Related side effects and adverse reactions
bronchial spasm
hypoglycemia
convulsive seizures
adrenergic beta-antagonists
hemangioma, capillary
propranolol

---
https://ansm.sante.fr/tableau-marr/icodextrine
2023
false
false
false
France
French
risk management
guidelines for drug use
peritoneal dialysis
blood glucose self-monitoring
Icodextrin

---
https://ansm.sante.fr/tableau-marr/atidarsagene-autotemcel
2023
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
Atidarsagene Autotemcel
risk management
infusions, intravenous
gene therapy
atidarsagene autotemcel
biological products

---
https://ansm.sante.fr/tableau-marr/eculizumab
2023
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
drug monitoring
patient safety
sepsis
meningococcal infections
risk
vaccination
antibiotic prophylaxis
adult
child
infant
patients guideline
patient education handout

---
Nous contacter.
21/04/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.